- Home
- ALLK vs FORA Comparison
ALLK vs FORA Comparison
Compare ALLK & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- FORA
- Stock Information
- Founded
- ALLK 2012
- FORA 2014
- Country
- ALLK United States
- FORA United States
- Employees
- ALLK N/A
- FORA N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- ALLK Health Care
- FORA Technology
- Exchange
- ALLK Nasdaq
- FORA Nasdaq
- Market Cap
- ALLK 58.0M
- FORA 63.8M
- IPO Year
- ALLK 2018
- FORA N/A
- Fundamental
- Price
- ALLK $1.16
- FORA $2.00
- Analyst Decision
- ALLK Hold
- FORA Strong Buy
- Analyst Count
- ALLK 5
- FORA 1
- Target Price
- ALLK $1.67
- FORA $5.00
- AVG Volume (30 Days)
- ALLK 1.3M
- FORA 13.3K
- Earning Date
- ALLK 11-06-2024
- FORA 11-13-2024
- Dividend Yield
- ALLK N/A
- FORA N/A
- EPS Growth
- ALLK N/A
- FORA N/A
- EPS
- ALLK N/A
- FORA N/A
- Revenue
- ALLK N/A
- FORA $19,709,723.00
- Revenue This Year
- ALLK N/A
- FORA N/A
- Revenue Next Year
- ALLK N/A
- FORA $10.64
- P/E Ratio
- ALLK N/A
- FORA N/A
- Revenue Growth
- ALLK N/A
- FORA N/A
- 52 Week Low
- ALLK $0.54
- FORA $1.99
- 52 Week High
- ALLK $3.41
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- ALLK 51.18
- FORA 34.88
- Support Level
- ALLK $1.29
- FORA $2.03
- Resistance Level
- ALLK $1.56
- FORA $2.13
- Average True Range (ATR)
- ALLK 0.14
- FORA 0.08
- MACD
- ALLK -0.03
- FORA 0.00
- Stochastic Oscillator
- ALLK 14.89
- FORA 4.76
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.